metoclopramide
SMILES | CCN(CCNC(=O)c1cc(Cl)c(cc1OC)N)CC |
InChIKey | TTWJBBZEZQICBI-UHFFFAOYSA-N |
Chemical properties
Hydrogen bond acceptors | 4 |
Hydrogen bond donors | 2 |
Rotatable bonds | 7 |
Molecular weight (Da) | 299.1 |
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT4 | 5HT4R | Rat | 5-Hydroxytryptamine | A | pKi | 6.01 | 6.02 | 6.05 | ChEMBL |
D2 | DRD2 | Bovine | Dopamine | A | pKi | 7.1 | 7.1 | 7.1 | ChEMBL |
D2 | DRD2 | Rat | Dopamine | A | pKi | 6.52 | 6.72 | 6.98 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pKi | 7.19 | 7.29 | 7.38 | ChEMBL |
5-HT1D | 5HT1D | Human | 5-Hydroxytryptamine | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
5-HT1D | F1MMU1 | Bovine | 5-Hydroxytryptamine | A | pKi | 5.05 | 5.05 | 5.05 | PDSP Ki database |
5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 8.22 | 8.22 | 8.22 | Drug Central |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 5.98 | 5.98 | 5.98 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 8.19 | 8.19 | 8.19 | Drug Central |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 6.4 | 6.4 | 6.4 | ChEMBL |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 8.23 | 8.23 | 8.23 | Drug Central |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 5.9 | 5.9 | 5.9 | ChEMBL |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.22 | 8.22 | 8.22 | Drug Central |
α2A | ADA2A | Human | Adrenoceptors | A | pKi | 5.99 | 5.99 | 5.99 | ChEMBL |
D1 | DRD1 | Human | Dopamine | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
D2 | DRD2 | Human | Dopamine | A | pKi | 8.14 | 8.14 | 8.14 | Drug Central |
D2 | DRD2 | Human | Dopamine | A | pKi | 7.19 | 7.19 | 7.19 | PDSP Ki database |
D3 | DRD3 | Human | Dopamine | A | pKi | 8.12 | 8.12 | 8.12 | Drug Central |
D3 | DRD3 | Human | Dopamine | A | pKi | 7.8 | 7.8 | 7.8 | PDSP Ki database |
D3 | DRD3 | Human | Dopamine | A | pKi | 7.17 | 7.51 | 7.8 | ChEMBL |
5-HT6 | 5HT6R | Rat | 5-Hydroxytryptamine | A | pKi | 5.3 | 5.3 | 5.3 | PDSP Ki database |
5-HT2A | 5HT2A | Rat | 5-Hydroxytryptamine | A | pKi | 5.65 | 5.67 | 5.69 | PDSP Ki database |
5-HT4 | 5HT4R | Rat | 5-Hydroxytryptamine | A | pKi | 8.22 | 8.22 | 8.22 | Drug Central |
5-HT2C | 5HT2C | Rat | 5-Hydroxytryptamine | A | pKi | 5.0 | 5.21 | 5.41 | PDSP Ki database |
5-HT4 | 5HT4R | Mouse | 5-Hydroxytryptamine | A | pKi | 8.22 | 8.22 | 8.22 | Drug Central |
5-HT4 | 5HT4R | Mouse | 5-Hydroxytryptamine | A | pKi | 5.4 | 5.62 | 6.05 | PDSP Ki database |
5-HT4 | 5HT4R | Mouse | 5-Hydroxytryptamine | A | pKi | 6.0 | 6.0 | 6.0 | Guide to Pharmacology |
D2 | DRD2 | Mouse | Dopamine | A | pKi | 8.12 | 8.12 | 8.12 | Drug Central |
D2 | DRD2 | Mouse | Dopamine | A | pKi | 7.54 | 7.54 | 7.54 | Guide to Pharmacology |
D2 | DRD2 | Bovine | Dopamine | A | pKi | 8.15 | 8.15 | 8.15 | Drug Central |
H1 | HRH1 | Rat | Histamine | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
β2 | ADRB2 | Rat | Adrenoceptors | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
5-HT7 | 5HT7R | Rat | 5-Hydroxytryptamine | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
D2 | DRD2 | Rat | Dopamine | A | pKi | 8.16 | 8.16 | 8.16 | Drug Central |
D2 | DRD2 | Rat | Dopamine | A | pKi | 6.63 | 7.36 | 8.38 | PDSP Ki database |
5-HT2C | K7GSR7 | Pig | 5-Hydroxytryptamine | A | pKi | 5.4 | 5.4 | 5.4 | PDSP Ki database |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
5-HT4 | 5HT4R | Rat | 5-Hydroxytryptamine | A | pEC50 | 5.72 | 5.91 | 6.1 | ChEMBL |
D3 | DRD3 | Rat | Dopamine | A | pIC50 | 7.21 | 7.21 | 7.21 | ChEMBL |
D2 | DRD2 | Rat | Dopamine | A | pIC50 | 6.09 | 6.25 | 6.35 | ChEMBL |
D2 | DRD2 | Human | Dopamine | A | pIC50 | 6.9 | 6.9 | 6.9 | ChEMBL |
5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pIC50 | 5.43 | 5.43 | 5.43 | ChEMBL |
5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pIC50 | 6.2 | 6.2 | 6.2 | ChEMBL |
5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pIC50 | 5.62 | 5.62 | 5.62 | ChEMBL |
5-HT4 | 5HT4R | Human | 5-Hydroxytryptamine | A | pEC50 | 8.22 | 8.22 | 8.22 | Drug Central |
5-HT4 | 5HT4R | Human | 5-Hydroxytryptamine | A | pEC50 | 6.1 | 6.1 | 6.1 | ChEMBL |
α2A | ADA2A | Human | Adrenoceptors | A | pIC50 | 5.57 | 5.57 | 5.57 | ChEMBL |
D3 | DRD3 | Human | Dopamine | A | pIC50 | 6.7 | 6.7 | 6.7 | ChEMBL |
D3 | DRD3 | Rat | Dopamine | A | pIC50 | 8.14 | 8.14 | 8.14 | Drug Central |
M1 | ACM1 | Rat | Acetylcholine (muscarinic) | A | Potency | 7.45 | 7.45 | 7.45 | ChEMBL |